Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Generalized Myasthenia Gravis peptide trials
3 selected ClinicalTrials.gov records carrying the official condition label Generalized Myasthenia Gravis. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
3 selected records.
1 profiles.
2026–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 11 selected PubMed records and 1 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Generalized Myasthenia Gravis unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT06055959
PeptideScanner retained ClinicalTrials.gov record NCT06055959 at 2026-11-15T21:46:36.651Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was zilucoplan.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- November 5, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT06435312
PeptideScanner retained ClinicalTrials.gov record NCT06435312 at 2026-11-15T21:46:36.651Z. Its registry update date was 2026-10-02, and PeptideScanner's reviewed identity mapping was zilucoplan.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- October 2, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT06471361
PeptideScanner retained ClinicalTrials.gov record NCT06471361 at 2026-11-15T21:46:36.651Z. Its registry update date was 2026-03-27, and PeptideScanner's reviewed identity mapping was zilucoplan.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- March 27, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Zilucoplan · 2026-11-05
ClinicalTrials.gov record NCT06055959
Recruiting at the retained observation.
Open attributed record →Zilucoplan · 2026-10-02
ClinicalTrials.gov record NCT06435312
Enrolling by invitation at the retained observation.
Open attributed record →Zilucoplan · 2026-03-27
ClinicalTrials.gov record NCT06471361
Completed at the retained observation.
Open attributed record →